Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
Clinical trial NCT00320879 · COMPLETED
Trial details
- NCT number
- NCT00320879
- Sponsor
- Steno Diabetes Center Copenhagen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.